XML 35 R21.htm IDEA: XBRL DOCUMENT v3.25.2
Shares and Stockholders’ Equity
6 Months Ended
Jun. 30, 2025
Stockholders' Equity Note [Abstract]  
Shares and Stockholders' Equity Shares and Stockholders’ Equity
Preferred Shares

Preferred stock authorized, issued and outstanding (number of shares) was as follows:

As of June 30, 2025As of December 31, 2024
Shares AuthorizedShares IssuedShares OutstandingShares AuthorizedShares IssuedShares Outstanding
9.250% Fixed Rate Reset Non-Cumulative
Preferred Stock, Series C20,000 20,000 20,000 20,000 20,000 20,000 
9.000% Non-Cumulative Preferred Stock,
  Series D
20,000 20,000 20,000 20,000 20,000 20,000 
Not designated9,960,000 – – 9,960,000 – – 
Total preferred shares10,000,000 40,000 40,000 10,000,000 40,000 40,000 

The per share and aggregate dividends declared for preferred stock by series (in millions except per share data) was as follows:

For the Three Months Ended June 30,
20252024
DividendAggregateDividendAggregate
SeriesPer ShareDividendPer ShareDividend
Series C$– $– $– $– 
Series D562.50 11 562.50 11 
Total$562.50 $11 $562.50 $11 

For the Six Months Ended June 30,
20252024
DividendAggregateDividendAggregate
SeriesPer ShareDividendPer ShareDividend
Series C$1,156.25 $23 $1,156.25 $23 
Series D1,125.00 23 1,125.00 23 
Total$2,281.25 $46 $2,281.25 $46 
Common Shares

The changes in our common stock (number of shares) were as follows:

 For the Three
Months Ended
June 30,
 For the Six
Months Ended
June 30,
2025202420252024
Common Stock
Balance as of beginning-of-period170,695,166 170,016,887 170,380,646 169,666,137 
Issuance of common stock18,759,497 – 18,759,497 – 
Stock compensation/issued for benefit
  plans
116,241 171,600 430,761 522,350 
Balance as of end-of-period189,570,904 170,188,487 189,570,904 170,188,487 

Our common stock is without par value.

Issuance of Common Stock

On June 5, 2025, we closed the previously announced stock purchase agreement (the “Purchase Agreement”) with Bain Capital Prairie, LLC (the “Buyer”), a newly formed subsidiary of Bain Capital, under which we agreed to sell shares representing 9.9% of our outstanding common stock on a post-issuance basis to the Buyer. Under the final terms, Lincoln issued 18,759,497 shares of common stock at $44.00 per share, based on a 25% premium to the 30-day volume-weighted average price as of April 8, 2025, for aggregate consideration of $825 million.

The Purchase Agreement provides for, among other things, certain limitations on the Buyer’s and certain of its affiliates’ ability to transfer common stock, purchase additional common stock, and take certain other actions with respect to the Company and its common stock, and an agreement that the Buyer and certain of its affiliates will, subject to certain limitations, vote common stock they beneficially own in favor of the matters recommended for approval by the Company’s board of directors (the “Board”). The Purchase Agreement also grants the Buyer the right to designate one observer to be present in a nonvoting capacity at all meetings of the Board and, following the first anniversary of the closing of the Transaction, the right to replace such observer with a voting member of the Board, in each case subject to the Buyer’s satisfaction of certain conditions and approval of the Board.
Earnings Per Share

The calculation of earnings per share (“EPS”) was as follows (in millions except per share data):

 For the Three
Months Ended
June 30,
 For the Six
Months Ended
June 30,
2025202420252024
Net income (loss) available to common stockholders – basic$688 $884 $(69)$2,070 
Deferred units of LNC stock in our
deferred compensation plans (1)
– – – 
Net income (loss) available to common
stockholders – diluted$688 $884 $(69)$2,073 
Weighted-average shares, as used in basic calculation177,175,326170,620,161174,264,554170,335,077
Incremental common shares from assumed exercise or
issuance of stock-based incentive compensation awards2,773,0601,553,4022,769,3201,324,837
Average deferred compensation shares (1)
654,279 719,003– 703,742
Weighted-average shares, as used in diluted calculation (2)
180,602,665172,892,566177,033,874172,363,656
Net income (loss) per share:
Basic$3.88 $5.18 $(0.39)$12.16 
Diluted3.80 5.11 (0.39)12.03 

(1)    We have participants in our deferred compensation plans who selected LNC stock as the measure for the investment return attributable to all or a portion of their deferral amounts. This obligation is settled in either cash or LNC stock pursuant to the applicable plan document. We exclude deferred units of LNC stock that are antidilutive from our diluted EPS calculation.
(2)     Due to reporting a net loss for the six months ended June 30, 2025, basic shares were used in the diluted EPS calculation for this period as the use of diluted shares would have resulted in a lower loss per share.

In the event the average market price of LNC common stock exceeds the issue price of stock options and the options have a dilutive effect to our EPS, such options will be shown in the table above.